Research and News Involving:
Drug
This is where the drug category posts show up.
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Pediatric, Rare Disease, University of California San Francisco
Press Release: Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Clinical Repurposing Trials in Bladder Cancer...
Adult, Advocate Aurora Health, Chicago, Clinical Trials, Dr. Elfar, Drug, Edward Hines Jr. VA Hospital and CARES, Military/Veteran, Neuro, Pennsylvania State University, Rush University Medical Center, University of New Mexico
Press Release: Cures Within Reach announces upcoming clinical trials to address veterans’ issues Cures Within Reach announces upcoming clinical trials to address veterans’ issues These two new trials will join its Veterans Initiative research portfolio...
Adult, Cincinnati Children's Hospital Medical Center, Clinical Trials, Developing World, Device, Drug, Emory University, Health Disparities, Minority/Underrepresented, Neuro, Oncology, Rare Disease, SIDS Hospital and Research Centre, Stanford University, University College Hospital Ibadan, University of California Los Angeles, University of Illinois at Chicago
Press Release: Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Cures Within Reach seeks clinical trials in health disparities or led by underserved researchers Ten clinical trials starting soon in Diversity, Equity...
Adult, Clinical Trials, DEBRA Chile, Dr. Gordon, Dr. Rower, Dr. Teng, Drug, Minority/Underrepresented, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Virtual Pitch Event on June 10 Features 4 Pediatric...
Clinical Trials, Drug, Patient Impact Awards
Press Release: Cures Within Reach Names Two Recipients of its 2021 Patient Impact Awards Cures Within Reach Names Two Recipients of its 2021 Patient Impact AwardsVirtual Pitch Event on June 10 Features 4 Pediatric Clinical Repurposing ProjectsReFRAME at Scripps...
Adult, Chicago, Clinical Trials, Dr. Liotta, Dr. Meltzer, Dr. Rado, Drug, Edward Hines Jr. VA Hospital and CARES, Health Disparities, Infectious Disease, Loyola University Medical Center, Military/Veteran, Neuro, Northwestern University, Oncology, Rare Disease, Shirley Ryan AbilityLab, University of Chicago, Women's Health
Press Release: Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Clinical Repurposing Trials for COVID-19 and Cerebral Palsy Underway in Chicago Trials at the University of Chicago, Northwestern University and Shirley Ryan AbilityLab...
Adult, Clinical Trials, Developing World, Dr. Chang, Dr. Mehta, Dr. Osman, Drug, Emory University, George Washington University, Infectious Disease, LMICs, Minority/Underrepresented, Openbiome, Pediatric, SIDS Hospital and Research Centre
Press Release: OpenBiome Researcher Wins CureAccelerator Live! for the Developing World OpenBiome Researcher Wins CureAccelerator Live! for the Developing World Clinical Trial for Severe Acute Malnutrition Receives Funding to Repurpose Existing Fecal Microbiota...
Adult, Clinical Trials, Developing World, Dr. Chang, Dr. Mehta, Dr. Osman, Drug, Infectious Disease, LMICs, Minority/Underrepresented, Oncology, Openbiome, Pediatric, SIDS Hospital and Research Centre
Press Release: Finalists Announced for CureAccelerator Live! Competition, Impacting Patients in Developing World Finalists Announced for CureAccelerator Live! Competition, Impacting Patients in Developing World Pitch Event on May 23 in Boston Features 5 Medical...
Adult, Clinical Trials, Dr. Elfar, Drug, Mid-Atlantic, Military/Veteran, Neuro, Pennsylvania State University
Press Release: Penn State College of Medicine Researcher Wins 2018 CureAccelerator Live! Penn State College of Medicine Researcher Wins 2018 CureAccelerator Live! Severe Limb Trauma Clinical Trial Receives Funding to Repurpose Existing Multiple Sclerosis Treatment...
Chicago, Clinical Trials, Dr. Weir, Drug, Patient Impact Awards
Press Release: Dr. Scott Weir Named Research Recipient of 2018 Global Health Repurposing Awards Dr. Scott Weir Named Research Recipient of 2018 Global Health Repurposing Awards Cures Within Reach will honor Dr. Weir on June 26 at its 6th annual gala February 27, 2018...
Adult, Current Research, Dermatology, Developing World, Dr. Johnson, Drug, Infectious Disease, LMICs, Minority/Underrepresented, Pediatric, ReGRoW, Université d'Abomey-Calavi
Adding Beta-lactam Antibiotics to Shorten Buruli Ulcer Disease Therapy in Benin Principal Investigator: Dr. Roch Christian Johnson Disease: Buruli ulcer Research Description: Buruli ulcer (BU), a neglected tropical disease, is a chronic debilitating mycobacterial...
Adult, Current Research, Developing World, Dr. Malichewe, Drug, LMICs, Minority/Underrepresented, Muhimbili University Health and Allied Sciences, Oncology, Rare Disease, ReGRoW
Testing a Generic Drug Combination to Treat AML in Tanzania Principal Investigator: Dr. Christina Malichewe Disease: Acute Myeloid Leukemia Research Description: Acute myeloid leukemia (AML) is a blood cancer that is difficult to manage, and patients may have shorter...
Adult, Current Research, Dr. Filippopulos, Dr. Zwergal, Drug, Ear Nose Throat, University Hospital of Munich
Treating Vestibular Neuritis Symptoms with a Thyroid Hormone Principal Investigators: Drs. Andreas Zwergal and Filipp Filippopulos Disease: Meniere’s disease Research Description: Acute unilateral vestibulopathy (AUVP), also known as vestibular neuritis, is the...
Current Research, Dr. Navaratnam, Drug, Ear Nose Throat, Pre-clinical, Yale University
Investigating the Effects of Blocking Immune Disease Pathways in Meniere’s Disease Principal Investigator: Dr. Dhasakumar Navaratnam Disease: Meniere’s disease Research Description: Meniere’s disease is an inner ear disorder that causes a number of...
Adult, Busitema University, Current Research, Developing World, Dr. Musaba, Drug, LMICs, Minority/Underrepresented, Pediatric, ReGRoW, Women's Health
Using Sodium Bicarbonate to Reduce Maternal / Fetal Death from Acidosis During Obstructed Labor in Uganda Principal Investigator: Dr. Milton Musaba Disease: Obstructed Labor Research Description: Obstructed labor (OL) poses a serious risk to both mother and infant,...
Colorado State University, Current Research, Dr. Regan, Drug, Oncology, Pre-clinical, Rare Disease
Evaluating an Approved Drug Combination Plus Immunotherapy in Canine Metastatic Osteosarcoma Principal Investigator: Dr. Daniel Regan Disease: Canine Metastatic Osteosarcoma Research Description: Metastasis remains the greatest challenge in osteosarcoma (OS) patient...
Adult, Current Research, Dr. Ghosh, Drug, Oncology, Rare Disease, University of Michigan
Reducing CAR T-cell therapy complications in relapsed lymphoma patients by adding natalizumab Principal Investigator: Dr. Monalisa Ghosh Disease: Relapsed Lymphoma Research Description: Chimeric antigen receptor (CAR) T-cell therapy offers new hope through...
Adult, Chicago, Current Research, Dr. Ibraheem, Drug, Minority/Underrepresented, Oncology, University of Illinois at Chicago, Women's Health
Using a Generic Drug Combination in Early-Stage Hormone Receptor Positive Breast Cancer Patients Principal Investigator: Dr. Abiola Ibraheem Disease: Breast Cancer Research Description: Preferred chemotherapy treatments for early-stage breast cancer are often...
Adult, Brigham Young University, Current Research, Dr. Watt, Drug, Oncology, Rare Disease
Treating Anemia in Myelofibrosis with Nelfinavir Principal Investigator: Dr. Richard Watt Disease: Myelofibrosis Research Description: Patients with myelofibrosis, an incurable blood cancer, often have chronic inflammation, which results in high levels of the hormone...
Adult, Current Research, Developing World, Dr. Zimba, Drug, LMICs, Minority/Underrepresented, Neuro, ReGRoW, University of Zambia School of Medicine
Testing an Antihypertensive Drug as an Add-On Therapy for Drug-Resistant Epilepsy Patients in Zambia Principal Investigator: Dr. Stanley Zimba Disease: Epilepsy Research Description: Epilepsy is the most common chronic neurological disease worldwide, affecting...
